Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -2.01%273.34K | |||||||||
| Gross profit | 2.01%-273.34K | |||||||||
| Operating expense | -40.56%502.47K | -62.47%340.75K | 41.48%692.26K | 144.81%3.18M | 52.22%935.54K | 261.31%845.31K | 786.24%907.85K | 40.94%489.3K | -29.92%1.3M | 859.83%614.6K |
| Selling and administrative expenses | 102.75%187.69K | -73.60%102.67K | -26.53%83.5K | 98.28%738.65K | 25.28%143.5K | 16.59%92.57K | 341.73%388.91K | 25.53%113.66K | -65.93%372.53K | -83.97%114.54K |
| -General and administrative expense | 102.75%187.69K | -73.60%102.67K | -26.53%83.5K | 98.28%738.65K | 25.28%143.5K | 16.59%92.57K | 341.73%388.91K | 25.53%113.66K | -65.93%372.53K | -83.97%114.54K |
| Other operating expenses | -58.18%314.78K | -54.12%238.09K | 62.06%608.75K | 163.54%2.44M | 58.39%792.04K | 387.04%752.74K | 3,505.23%518.94K | 46.38%375.64K | 21.99%925.63K | 162.87%500.06K |
| Operating profit | 40.56%-502.47K | 62.47%-340.75K | -41.48%-692.26K | -144.81%-3.18M | -52.22%-935.54K | -261.31%-845.31K | -786.24%-907.85K | -40.94%-489.3K | 39.09%-1.3M | -210.31%-614.6K |
| Net non-operating interest income (expenses) | 98.41%-13.55K | -29.58%-18.66K | -83.12%-496.54K | -201.85%-1.21M | 13.42%-77.32K | -5,542.38%-850.59K | 3.16%-14.4K | 4.10%-271.16K | 22.67%-402.01K | -19.94%-89.31K |
| Non-operating interest expense | -98.41%13.55K | 29.58%18.66K | 83.12%496.54K | ---- | ---- | 5,542.38%850.59K | -3.16%14.4K | -4.10%271.16K | ---- | ---- |
| Total other finance cost | ---- | ---- | ---- | 201.85%1.21M | ---- | ---- | ---- | ---- | -22.67%402.01K | ---- |
| Other net income (expenses) | -50.54%53.09K | 69.66%212.43K | 6.68%132.18K | 224.11%403.19K | 113.70%46.73K | 575.24%107.35K | 220.01%125.21K | 40,461.24%123.91K | 19.09%-324.88K | -38.26%-341.11K |
| Gain on sale of security | -566.98%-28.18K | 1,640.53%78.61K | 106.14%408 | -1,134.04%-103.35K | -2,692.16%-97.64K | 128.13%6.04K | -130.07%-5.1K | -1,598.47%-6.64K | 86.36%-8.38K | -118.25%-3.5K |
| Special income (charges) | --0 | ---- | ---- | -236.47%-23.68K | 179.13%5.57K | ---29.25K | ---- | ---- | 96.79%-7.04K | 95.07%-7.04K |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -24.00%108.51K | ---- |
| -Less:Other special charges | ---- | ---- | ---- | -172.15%-20.32K | ---49.57K | --29.25K | ---- | ---- | -63.29%28.16K | ---- |
| -Less:Write off | ---- | ---- | ---- | 525.18%44K | ---- | ---- | ---- | ---- | --7.04K | ---- |
| Other non-operating income (expenses) | -37.75%81.27K | 2.69%133.82K | 0.94%131.77K | 271.34%530.23K | 141.99%138.8K | 11,633.83%130.56K | 488.11%130.31K | 155,316.67%130.55K | -156.54%-309.46K | -168.57%-330.57K |
| Income before tax | 70.86%-462.93K | 81.56%-146.99K | -65.99%-1.06M | -96.95%-3.99M | 7.55%-966.14K | -484.85%-1.59M | -919.45%-797.04K | -1.00%-636.55K | 33.66%-2.03M | -101.26%-1.05M |
| Income tax | 0 | 0 | 0 | 0 | 251.93%16.24K | |||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 70.86%-462.93K | 81.56%-146.99K | -65.99%-1.06M | -96.95%-3.99M | 8.96%-966.14K | -495.14%-1.59M | -983.76%-797.04K | -2.12%-636.55K | 33.06%-2.03M | -108.69%-1.06M |
| Net income continuous operations | 70.86%-462.93K | 81.56%-146.99K | -65.99%-1.06M | -96.95%-3.99M | 8.96%-966.14K | -495.14%-1.59M | -983.76%-797.04K | -2.12%-636.55K | 33.06%-2.03M | -108.69%-1.06M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 70.86%-462.93K | 81.56%-146.99K | -65.99%-1.06M | -96.95%-3.99M | 8.96%-966.14K | -495.14%-1.59M | -983.76%-797.04K | -2.12%-636.55K | 33.06%-2.03M | -108.69%-1.06M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 70.86%-462.93K | 81.56%-146.99K | -65.99%-1.06M | -96.95%-3.99M | 8.96%-966.14K | -495.14%-1.59M | -983.76%-797.04K | -2.12%-636.55K | 33.06%-2.03M | -108.69%-1.06M |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%-0.01 | 0 | -839.85%-0.01 | 0 | 0 | 0.00%-0.01 | -0.0061 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%-0.01 | 0 | -839.85%-0.01 | 0 | 0 | 25.69%-0.01 | -77.64%-0.0061 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.